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Anatomical connections of the functionally-defined “face patches” in the macaque 
monkey: Supplementary Online Material 
 
Supplementary Experimental Procedures 
 
Face patch localization. Three male rhesus monkeys (6-10 kg) were implanted with ultem 
headposts, as described in Tsao et al. (2008). All procedures conformed to local and US National 
Institutes of Health guidelines, including the US National Institutes of Health Guide for Care and 
Use of Laboratory Animals. They were trained via standard operant conditioning techniques to 
maintain fixation on a small spot for a juice reward and then scanned in a TIM TRIO (Siemens) 
horizontal bore magnet equipped with AC88 gradient insert to identify face-selective regions using 
MION contrast agent. Eye position was monitored using an infrared pupil tracking system (RK-
726PCI, ISCAN Inc.). The stimuli were displayed at 60 Hz with a resolution of 1280 by 1024 pixels, 
using a video beamer (JVC DLA-G15E) and a back projection screen. For further details see 
(Tsao et al., 2006; Tsao et al., 2008). 
 
Multi-unit recording and eye-position monitoring. We recorded extracellularly with 
electropolished tungsten electrodes coated with vinyl lacquer (FHC), advanced using a manual 
advancer (Narishige). Neural signals were recorded and spikes were sorted online with dual-
window discrimination using Plexon. Single units and multiunits were filtered at 0.15-8 kHz and 
recorded at 40 kHz. Eye position was monitored with an infrared eye tracking system (ISCAN) at 
60 Hz with an angular resolution of 0.25°, calibrated before each recording session by having the 
monkey fixate dots at the center and four corners of the monitor. 
 
Visual stimuli for mapping face patches electrophysiologically. The monkey sat in a dark 
box with its head rigidly fixed and was given a juice reward for keeping fixation for 3 s in a 2.5° 
fixation box. Visual stimuli were presented using custom software and presented at a 60-Hz 
monitor refresh rate and 640 x 480 resolution on a BARCO ICD321 PLUS monitor. The monitor 
was positioned 53 cm in front of the monkey's eyes. Pictures subtended a 7°  7° region of the 
visual field. Pictures were presented for 100 ms, separated by 100 ms blank intervals in three 
experiments; 96 pictures from six different image categories (faces, human bodies, produce, 
technical objects, human hands and scrambled images) were shown. 
 
Targeting face patches for tracer injections. We injected two face patches in monkey N (left 
AM and right AL), four patches in monkey D (left PL, left ML, right AL and right AM) and 6 patches 
in monkey B (left PL, left ML, left AL, left AM, right ML and right AL). In Monkey B we also made 
a control injection outside of the face patches in the ventral bank of the STS (see Table 1).  
 
The face patches were targeted according to the MRI coordinates using custom software (Ohayon 
and Tsao, 2012). For each targeted patch, several grid holes spanning the region of strongest 
fMRI activation were identified. For each grid hole, we mapped the entire extent of face-selective 
cortex through recordings spaced every 40-200 µm; in each penetration the spacing between 
recording sites was constant. The grid hole with longest stretch of face-selective activity was 
elected for tracer injection. 
 
We chose a superficial approach for two injections (left PL and left ML in monkey D) and deep 
approach for all the other injections. For superficial recordings a CILUX chamber (Crist 
instruments), 19 mm inner diameter was placed on the temporal bone, centered on ML. For 
superficial injections, we thinned the dura mater in a small region of the chamber where the patch 
was expected to be. A tungsten rod was dipped in sterile black ink and placed through a grid on 
the surface of the dura, to label the expected location of the face patch according to the MRI 
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coordinates. To stabilize recordings, we used a sealed drive (Narishige) and the chamber was 
filled with mineral oil.  
 
On the day of the injection, recordings were performed prior to injection and the injection was 
made in the same hole and the same depth as where center of face-selective activity was found.  
 
Tracer Injections. Pressure injections were made with a 1 µl Hamilton syringe connected to a 
needle (deep injections) or a pulled glass capillary (superficial injections) via a Teflon tube filled 
with mineral oil. For deep injections we used a 27 gauge steel needle ending with a 45° beveled 
tip. The needle was mounted on the same drive we used for the electrode during recordings and 
advanced to the desired depth. For superficial injections, we pulled a capillary glass to a tip 
diameter ranging 30-50 µm (50 µm for Fast Blue and True Blue, 30 µm for all other tracers). On 
the day of the injection a small hole in the dura was made, corresponding to the location of the 
face patch. A recording was made to confirm face-selective activity and then the injection was 
made in the same spot. The glass pipette was fixed to the electrophysiology advancer and 
advanced until it touched the surface of the brain, and then further advanced 1.5 mm to target 
around layer IV. 
 
Both steel needles and glass pipettes were loaded with 1 µl of tracer. For deep injections, to avoid 
spillover of tracer along the penetration of the needle, 0.2 µl of air was sucked in the pipette after 
the tracer, to avoid contact of the tracer with the brain tissue. The needle was flushed with sterile 
saline and carefully dried with sterile gauze.  
 
For all injections we injected 0.2 µl of tracer over 10 minutes. For deep injections, after the end of 
the injection we waited 20 minutes with the needle sitting in place, then retracted for 500 µm and 
retracted the plunger of the syringe by 0.2 ul, waited another 30 minutes, and then slowly retracted 
to the surface.  
 
Superficial injections were made under microscope control, to check that the tracer was flowing 
in the pipette and that there was no leak of tracer on the surface. After the end of the injection the 
pipette was left in place for 30 minutes and then retracted. The dura slit was closed with artificial 
dura. 
 
 
The tracers used (see Table 1) were CTB-Alexa 488, CTB-Alexa 555 (1% in PBS, Invitrogen), 
Cascade Blue, Fluoro-Emerald, Lucifer Yellow, (10% in PBS; Life  
Technologies), Fast Blue (2% in distilled water, Polysciences), True Blue (5% in distilled water, 
Sigma Aldrich), and Biotinylated Dextran amine (BDA; 1% in PBS, Invitrogen).  
  
Perfusion and tissue processing. The injections were made on different days. On each day we 
recorded face selective neural activity and then made an injection. The animals were perfused 14 
days after the last injection and no longer than 21 days after the first injection.  
 
On the day of perfusion, the animal was anesthetized with ketamine (8 mg/kg, i.m) and sodium 
pentobarbital (50 mg/kg, Akorn Inc., i.v). When the skin and corneal reflexes were abolished we 
made a thoracic incision, exposed the heart, and perfused transcardially with 2 L of warm saline 
(37 °C) with heparin (5000 UI/L) followed by 3 L of 4% paraformaldehyde in 0.12 M phosphate 
buffer (PB), and finally 1 L of 4% paraformaldehyde and 10% sucrose in 0.12 M PB. At the end 
of the perfusion the brain was extracted from the skull, photographed, and postfixed for 4 hours 
in the final fixative/sucrose solution at 4 °C. It was then moved in a solution of 10% sucrose in 
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0.12 M PB for 2 days at 4°C on a rocking plate and then stored for 4 more days in 20% sucrose 
in 0.12 M PB. 
 
After cryoprotection the brain was blocked and cut coronally at 50 µm thick sections on a sliding 
microtome. We divided the sections into 10 series that were processed in different ways. For each 
brain different series of sections were treated for the different tracers (500 µm interval between 
adjacent sections in each series). Additional series of sections were processed with the Nissl or 
immunohistochemically with antibodies against parvalbumin (PV), and a nonphosphorylated 
epitope of the neurofilament protein, recognized by the SMI-32P antibody (see below). 
 
The fluorescent tracers Fast Blue and True Blue were examined from unstained sections. For 
other tracers, antibodies were used to enhance the fluorescence of the labeled neurons or 
terminals: anti-Alexa488 for CTB-488 (1:1000, Invitrogen), anti-Lucifer Yellow for Lucifer Yellow 
(1:1000, Invitrogen), anti-fluorescein/oregon green for Fluoro Emerald (1:1000, Invitrogen), and 
anti-Alexa 555/Cascade Blue for Cascade Blue (1:1000, Invitrogen). For immunofluorescence, 
the primary antibody was incubated overnight at room temperature on a rocking plate in PBS with 
5% gelatin and 0.25% Triton. The next day, the sections were rinsed 2 times in PBS for 10 minutes 
and incubated in the specific secondary antibody, linked to Alexa Fluor 488 (1:1000, Invitrogen) 
or to Cy3 (1:800, Jackson Immunoresearch) for one hour at room temperature. In some cases, 
cell nuclei were stained with 4′-6-diamidino-2-phenylindole (DAPI, Sigma Aldrich). At the end of 
processing, the slices were mounted on glass slides, air-dried, and cover-slipped with mounting 
media, Mowiol (Sigma).  
 
Some series were treated for immunohistochemistry (PV and SMI-32; Cascade Blue, Lucifer 
Yellow, and Fluoro Emerald were also processed immunohistochemically, in addition to 
immunofluorescence technique described above). In this case the slices were incubated in PBS 
with 0.3% H2O2 at room temperature for 2 hours and then incubated with the primary antibody in 
a solution of 4% gelatin and 0.25% TritonX overnight (Anti-Parvalbumin, 1:5000, Sigma Aldrich; 
Anti-SMI-32p, 1:1000, Covance). The next morning the slices were rinsed twice for 10 minutes in 
PBS and then incubated with the appropriate biotinylated secondary antibody for 4 hours (1:200, 
Vector Labs), rinsed in PBS again and incubated for one hour with the avidin/biotin staining kit 
(ABC kit, 1:50, Vector Labs). The slices were rinsed in PBS twice for 10 minutes and then in Tris 
HCl twice for 10 minutes and then incubated with a solution of diaminobenzidine (0.3%, Sigma 
Aldrich) and H2O2 (0.03%) in Tris HCl. The slices were periodically checked under the microscope 
and the reaction was stopped when needed. To develop BDA we incubated the slices in the ABC 
kit (1:50, Vector Labs) for one hour and then the reaction was enhanced with diaminobenzidine 
and nickel, to make the BDA labeling black and distinguishable from the other tracers. 
 
Data Analysis. 
MRI data analysis. We used FSFAST (http://surfer.nmr.mgh.harvard.edu) to perform functional 
MRI data analysis, following procedures described in (Tsao et al., 2008). To define face-selective 
areas we calculated the contrast faces versus all other objects, and selected contiguous regions 
of activated voxels at threshold p < 10-4 after spatial smoothing with a 1 mm full width at half 
maximum Gaussian. We used trilinear interpolation for visualization. 
 
For the analysis of the anatomical tracers we used Neurolucida system (Microbrightfield), 
attached to Nikon Eclipse microscope. For each series, we plotted the location and extent of the 
injection site and spatial distribution of labeled neurons. Low and high-power photomicrographs 
of labeled cells and terminals were acquired with the same microscope. Confocal images were 
acquired with an Olympus Fluoview confocal microscope. To quantify the number of cells inside 
and outside of the face patches every slice plotted with Neurolucida was converted into a jpeg 
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image and was overlapped in Photoshop to the corresponding fMRI slice at a threshold of 10-4 
and manually quantified. Slices between 1 mm anterior and 1 mm posterior of the injection site 
were not considered for quantitative analysis, because the dense labeling made the quantification 
of single cells impossible. The subdivisions of cortical areas, and sulci indicated in our illustrations 
are based on the Saleem and Logothetis atlas (Saleem and Logothetis, 2012). 
 
To generate flatmaps, the Neurolucida plottings were then registered to the MRI of the 
corresponding monkey brain with custom software allowing each Neurolucida slice to be manually 
aligned to its corresponding MRI slice, through 2D affine transform. The two hemispheres were 
registered independently. The software quantified the number of plotted cells in each voxel of the 
MRI and outputted a nifti file.  
 
Flatmaps were generated using Freesurfer (http://surfer.nmr.mgh.harvard.edu). For the layer 
analysis, supra- and infragranular layers, and layer IV were defined with NISSL or DAPI staining 
on adjacent sections. All the cell bodies lying superficial to layer IV were considered 
supragranular, all cell bodies located deeper to this layer were considered infragranular. Digital 
images (photomicrographs) were processed with Adobe Photoshop CS3 to adjust brightness and 
contrast and assemble the final plates.  
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Supplementary List of Abbreviations 
    
   
12l   ventrolateral prefrontal area        
12o   orbital prefrontal area         
13l   orbital prefrontal area 
13m  orbital prefrontal area 
36  area 36 of the perirhinal cortex       
  
45   ventrolateral prefrontal area  
AF  anterior fundus face patch 
AL  anterior lateral face patch 
AM  anterior medial face patch 
amg  amygdala  
amts   anterior middle temporal sulcus        
asl   arcuate sulcus lower limb 
asu  arcuate sulcus upper limb 
cas  calcarine sulcus 
cl  claustrum         
cs   central sulcus 
ICA  internal carotid artery           
ios   inferior occipital sulcus 
ips  intraparietal sulcus 
los  lateral orbital sulcus         
ls   lunate sulcus 
MF  middle fundus face patch   
ML  middle lateral face patch 
MTL  medial temporal lobe 
mos  medial orbital sulcus    
ots   occipitotemporal sulcus   
PL  posterior lateral face patch     
pmts   posterior middle temporal sulcus      
ps   principal sulcus 
rs  rhinal sulcus          
sf  sylvian fissure        
sts   superior temporal sulcus 
TEad   dorsal subregion of anterior TE       
TEav   ventral subregion of anterior TE 
TEm  area TEm, ventral bank of the sts      
TEO   area TEO       
TEpd   dorsal subregion of posterior TE      
TEpv   ventral subregion of posterior TE      
TF   area TF of the parahippocampal cortex      
TFO   area TFO of the parahippocampal cortex     
TH   area TH of the parahippocampal cortex 
TPO    area TPO (dorsal bank of the sts)   
V1   visual area 1 (primary visual cortex)     
V2   visual area 2            
V3   visual area 3, dorsal part       
V3v   visual area 3, ventral part       
V4   visual area 4 (dorsal part)         
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V4v   visual area 4, ventral part 
WM  white matter       
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Supplementary Table and Figure Legends 
 
Table S1, related to Table 1. Quantification of the cell bodies found in each anatomical area after 
different face patch injections in three cases. First column on the left indicates the name of the 
animals and the injected face patches. The first row shows the name of the anatomical regions 
where cell bodies were found. From left to right: all the face patches in the left and right 
hemisphere (an “x” indicates that the face patch was missing in the particular case), cells in IT 
cortex outside of the face patches, cortical areas outside of IT including lateral and orbital 
prefrontal cortex (dl PFC and OFC), caudal inferotemporal area TEO, caudal visual areas (V2, 
V3, V4), perirhinal, and parahippocampal cortex (areas TF, TFO, and TH), and subcortical regions 
(pulvinar, amygdala, and claustrum). For cortical areas we indicate the percentage of cells in the 
superficial layers (sup. l). 
 
  
Suppl. Figure 1, related to Figure 1. Distribution of retrogradely-labeled cells in the temporal 
lobe after CB injection into left PL (case Monkey B), conventions as in Figure 1. (A) Lateral view 
of the left hemisphere indicating the trajectory of the electrode (and injection cannula) into PL. (B, 
C) The trajectory of actual electrode into this face patch, in coronal and sagittal-like MR images. 
(D) Normalized responses of cells along one penetration (spaced 100 µm apart) into PL. (E) 
Rostrocaudal level of coronal MR slices illustrated in this figure. (F) Coronal MRI slice showing 
the location of left PL. (G) Corresponding histology slice in the frozen brain block. The blue spot 
indicates the CB injection site. (H) High-power fluorescent photomicrograph of the injection site, 
which was confined within PL. Inset shows the same injection site in bright-field photomicrograph, 
developed with DAB. (I, L, O, R) Coronal MR images with face-selective activation overlaid. (J, 
M, P, S) Plottings of retrogradely-labeled neurons. (K, N, Q, T) Low-power photomicrographs of 
CB-labeled cells from TE (rectangular box in J), TEO (rectangular boxes in M and P), and V2 
(rectangular box in S). Inset: high-power photomicrographs of labeled neurons. (U) Flatmap of 
left occipito-temporal areas with face-selective activation overlaid. (V) Flatmap with density of 
labeled cells overlaid. (W) Flatmap with density of labeled cells superimposed on face patches. 
Note that almost all the clusters of labeled neurons within IT were localized within the face patches 
(shown in W). 
 
 
Suppl. Figure 2, related to Figure 2. Distribution of retrogradely-labeled cells in the temporal 
lobe after CTB-555 injection into left ML (case Monkey B), conventions as in Figure 1. (A) Lateral 
view of the left hemisphere indicating the trajectory of the electrode (and injection cannula) into 
ML. (B, C) The trajectory of actual electrode into this face patch, in coronal and sagittal-like MR 
images. (D) Normalized responses of cells along one penetration (spaced 50 µm apart) into ML. 
(E) Rostrocaudal level of coronal MR slices illustrated in this figure. (F) Coronal MRI slice showing 
the location of both left ML, left MF, right ML and right MF. (G) Corresponding histology slice in 
the frozen brain block. The red spot indicates the CTB-555 injection site. (H) High-power 
fluorescent photomicrograph of the injection site, which was confined within ML. (I, L, O, R, R’) 
Coronal MR images with face-selective activation overlaid. (J, M, P, S, S’) Plottings of 
retrogradely-labeled neurons. (K, N, Q, T, T’) Low-power photomicrographs of CTB-555-labeled 
cells from TE (rectangular boxes in J, M, P) and TEO (rectangular boxes in R and S). Insets: high-
power photomicrographs of labeled neurons. Panels (S, T) show connections from AP to both AL 
and ML (cf. Figure S4). (U) Flatmap of left visual cortex with face-selective activation overlaid. (V) 
Flatmap with density of labeled cells overlaid. (W) Flatmap with density of labeled cells 
superimposed on face patches. Note that almost all the clusters of labeled neurons were localized 
within the face patches (shown in W). 
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Suppl. Figure 3, related to Figure 2. Distribution of retrogradely-labeled cells in the temporal 
lobe after CTB-488/LY injection into right ML (case Monkey B), conventions as in Figure 1. (A) 
Lateral view of the right hemisphere indicating the trajectory of the electrode (and injection 
cannula) into ML. (B, C) The trajectory of actual electrode into this face patch, in coronal and 
sagittal-like MR images. (D) Normalized responses of cells along one penetration (spaced 50 µm 
apart) into ML. (E) Rostrocaudal level of coronal MR slices illustrated in this figure. (F) Coronal 
MRI slice showing the location of both left ML and right ML. (G) Corresponding histology slice in 
the frozen brain block. The green spot indicates the CTB-488/LY injection site. (H) High-power 
fluorescent photomicrograph of the injection site, which was confined within ML. (I, L, O, R) 
Coronal MR images with face-selective activation overlaid. (J, M, P, S) Plottings of retrogradely-
labeled neurons. (K, N, Q, T) Low-power photomicrographs of CTB-488/LY-labeled cells from TE 
(rectangular boxes in J, M) and V4 (rectangular boxes in P, S). Insets: high-power 
photomicrographs of labeled neurons. (U) Flat map of right occipito-temporal areas with face-
selective activation overlaid. (V) Flatmap with density of labeled cells overlaid. (W) Flatmap with 
density of labeled cells superimposed on face patches. Note that almost all the clusters of labeled 
neurons were localized within the face patches (shown in W). 
 
 
Suppl. Figure 4, related to Figure 3. Distribution of retrogradely-labeled cells in the temporal 
lobe after FE injection into left AL (case Monkey B), conventions as in Figure 1. (A) Lateral view 
of the left hemisphere indicating the trajectory of the electrode (and injection cannula) into AL. (B, 
C) The trajectory of actual electrode into this face patch, in coronal and sagittal-like MR images. 
(D) Normalized responses of cells along one penetration (spaced 100 µm apart) into AL. (E) 
Rostrocaudal level of coronal MR slices illustrated in this figure. (F) Coronal MRI slice showing 
the location of the left AL. (G) Corresponding histology slice in the frozen brain block. The green 
spot indicates the FE injection site. (H) High-power fluorescent photomicrograph of the injection 
site, which was confined within AL. (I, L, O, R) Coronal MR images with face-selective activation 
overlaid. (J, M, P, S) Plottings of retrogradely-labeled neurons. (K, N, Q, T) Low-power 
photomicrographs of FE-labeled cells from TE (rectangular boxes in J, M) and TEO (rectangular 
boxes in P and S). Insets: high-power photomicrographs of labeled neurons. (U) Flat map of the 
left occipito-temporal areas with face-selective activation overlaid. (V) Flatmap with density of 
labeled cells overlaid. (W) Flatmap with density of labeled cells superimposed on face patches. 
Note that almost all the clusters of labeled neurons were localized within the face patches (shown 
in W). 
 
 
Suppl. Figure 5, related to Figure 3. Distribution of retrogradely-labeled cells in the temporal 
lobe after FB injection into right AL (case Monkey B), conventions as in Figure 1. (A) Lateral view 
of the right hemisphere indicating the trajectory of the electrode (and injection cannula) into AL. 
(B, C) The trajectory of actual electrode into this face patch in coronal and sagittal-like MR images. 
(D) Normalized responses of cells along one penetration (spaced 40 µm apart) into AL. (E) 
Rostrocaudal level of coronal MR slices illustrated in this figure. (F) Coronal MRI slice showing 
the location of the right and left AL. Note that the right AL in this case is located between sts and 
amts, but the left AL is located at the ventral lip of the sts, as in other cases (G) Corresponding 
histology slice in the frozen brain block. The blue spot indicates the FB injection site. (H) High-
power fluorescent photomicrograph of the injection site, which was confined within AL. (I, L, O, 
R) Coronal MR images with face-selective activation overlaid. (J, M, P, S) Plottings of 
retrogradely-labeled neurons. (K, N, Q, T) Low-power photomicrographs of FB-labeled cells from 
TE (rectangular box in J), and TEO (rectangular boxes in M, P, S). Insets: high-power 
photomicrographs of labeled neurons. (U) Flatmap of right hemisphere (occipito-temporal areas) 
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with face-selective activation overlaid. (V) Flatmap with density of labeled cells overlaid. (W) 
Flatmap with density of labeled cells superimposed on face patches. Note that most clusters of 
labeled neurons were localized within the face patches (shown in W). 
 
Suppl. Figure 6, related to Figure 3. Distribution of retrogradely-labeled cells in the temporal 
lobe after CB injection into right AL (case Monkey D), conventions as in Figure 1. (A) Lateral view 
of the right hemisphere indicating the trajectory of the electrode (and injection cannula) into AL. 
(B, C) The trajectory of actual electrode into this face patch, in coronal and sagittal-like MR 
images. (D) Normalized responses of cells along one penetration (spaced 100 µm apart) into AL. 
(E) Rostrocaudal level of coronal MR slices illustrated in this figure. (F) Coronal MRI slice showing 
the location of the right AL, AM and AF and left AM. (G) Corresponding histology slice in the 
frozen brain block. The blue spot indicates the CB injection site. (H) High-power fluorescent 
photomicrograph of the injection site, which was confined within AL. (I, L, O, R) Coronal MR 
images with face-selective activation overlaid. (J, M, P, S) Plottings of retrogradely-labeled 
neurons. (K, N, Q, T) Low-power photomicrographs of FB-labeled cells from TE (rectangular 
boxes in J, M, P, S). Insets: high-power photomicrographs of labeled neurons. (U)  Flatmap of the 
right visual cortex with face-selective activation overlaid. (V) Flatmap with density of labeled cells 
overlaid. (W)  Flatmap with density of labeled cells superimposed on face patches. Note that most 
clusters of labeled neurons were localized within the face patches (shown in W). 
 
Suppl. Figure 7, related to Figure 4. Distribution of retrogradely-labeled cells in the temporal 
lobe after LY injection into right AM (case Monkey D), conventions as in Figure 1. (A) Lateral view 
of the right hemisphere indicating the trajectory of the electrode (and injection cannula) into AM. 
(B, C) The trajectory of actual electrode into this face patch, in coronal and sagittal-like MR 
images. (D) Normalized responses of cells along one penetration (spaced 100 µm apart) into AL. 
(E) Rostrocaudal level of coronal MR slices illustrated in this figure. (F) Coronal MRI slice showing 
the location of the right AM (G) Corresponding histology slice in the frozen brain block. The green 
spot indicates the LY injection site. (H) High-power fluorescent photomicrograph of the injection 
site, which was confined within AM. (I, L, O, R, R’) Coronal MR images with face-selective 
activation overlaid. (J, M, P, S, S’) Plottings of retrogradely-labeled neurons. (K, N, Q, T, T’) Low-
power photomicrographs of LY-labeled cells from the PFC (rectangular box in J), and TE 
(rectangular boxes in M, P, S, S’). Insets: high-power photomicrographs of labeled neurons. (U) 
Flatmap of right visual cortex with face-selective activation overlaid. (V) Flatmap with density of 
labeled cells overlaid. (W) Flatmap with density of labeled cells superimposed on face patches. 
Note that most clusters of labeled neurons were localized within the face patches (shown in W). 
 
Suppl. Figure 8, related to Figure 4. Distribution of retrogradely-labeled cells in the temporal 
lobe after BDA injection into left AM (case Monkey B), conventions as in Figure 1. (A) Lateral view 
of the left hemisphere indicating the trajectory of the electrode (and injection cannula) into AM. 
(B, C) The trajectory of actual electrode into this face patch, in coronal and sagittal-like MR 
images. (D) Normalized responses of cells along one penetration (spaced 60 µm apart) into AM. 
(E) Rostrocaudal level of coronal MR slices illustrated in this figure. (F) Coronal MRI slice showing 
the location of the left AM. (G) Corresponding histology slice in the frozen brain block. The black 
spot indicates the BDA injection site. (H) High-power photomicrograph of the injection site, which 
was mainly confined within AM. Spillover of the tracer is visible in the overlying white matter. (I, 
L, O, R) Coronal MR images with face-selective activation overlaid. (J, M, P, S) Plottings of 
retrogradely-labeled neurons. (K, N, Q, T) Low-power photomicrographs of BDA-labeled cells 
from TE (rectangular boxes in J, M, P) and TEO (S). Insets: high-power photomicrographs of 
labeled neurons. (U) Flat map of left visual cortex with face-selective activation overlaid. (V) 
Flatmap with density of labeled cells overlaid. (W) Flatmap with density of labeled cells 
superimposed on face patches.  
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Suppl. Figure 9, related to Figures 1-4. Distribution of retrogradely-labeled cells in the temporal 
lobe after TB injection in a non-face selective spot in the lower bank of the sts located between 
AM and AL (control injection; case Monkey B), conventions as in Figure 1. (A) Lateral view of the 
left hemisphere indicating the trajectory of the electrode (and injection cannula) the injection spot. 
(B, C) The trajectory of actual electrode into this area, in coronal and sagittal-like MR images. (D) 
Normalized responses of cells along one penetration (spaced 50 µm apart). (E) Rostrocaudal 
level of coronal MR slices illustrated in this figure. (F) Coronal MRI slice showing the location of 
the injection site. (G) Corresponding histology slice in the frozen brain block. The blue spot 
indicates the TB injection site. (H) High-power fluorescent photomicrograph of the injection site. 
(I, L, O, R) Coronal MR images with face-selective activation overlaid. (J, M, P, S) Plottings of 
retrogradely-labeled neurons. (K, N, Q, T) Low-power photomicrographs of TB-labeled cells from 
TE (rectangular boxes in J, M, P, S). Inset: high-power photomicrographs of labeled neurons. (U)  
Flatmap of the left visual cortex with face-selective activation overlaid. (V) Flatmap with density 
of labeled cells overlaid. (W) Flatmap with density of labeled cells superimposed on face patches. 
Note that all the clusters of labeled neurons were localized outside of the face patches (shown in 
W).  
 
Suppl. Figure 10, related to Figures 1-4. Distribution of retrogradely-labeled cells in the 
contralateral hemisphere relative to the injection. (A, E, J, N, R, V) Lateral view of the brain 
indicating the trajectory of the electrode (and injection cannula). (B, F, K, O, S, W) Coronal MR 
images with face-selective activation overlaid on the contralateral hemisphere. (C, G, L, P, T, X) 
Plottings of retrogradely-labeled neurons. (D, H, M, Q, U, Y) Low-power photomicrographs of 
retrogradely labeled neurons (rectangular boxes in C, G, L, P, T, X). Insets: high power 
photomicrographs of labeled neurons. 
  
Suppl. Figure 11, related to Figure 5. Subcortical connections of different face patches. (A, D, 
G) Coronal MR images with claustrum outlined. (B) Distribution of retrogradely-labeled cells in 
the claustrum after FB injection into AL. Conventions as in Figure 5. (C) Low and high-power 
photomicrographs of FB labeled neurons (rectangle in B). (E) Distribution of retrogradely-labeled 
cells in the claustrum after CB injection into AL.  (F) Low power photomicrographs of CB-labeled 
neurons (rectangle in E). (H) Distribution of retrogradely-labeled cells in the claustrum after LY 
injection into AM. (I) Low power photomicrograph of LY-labeled neurons (rectangle in H). (J, M) 
Coronal MR images of the lateral pulvinar (pl). (K, N) Distribution of labeled neurons in the 
caudorostral extent of the lateral pulvinar (pl) after retrograde tracer CB injection into AL (K) and 
LY in AM (N). Note the complimentary and discontinuous patches of CB-labeled neurons at 
caudorostral level AP +2, and LY-labeled neurons at AP +2.5. (L, O) Low and high-power 
photomicrographs of CB- and LY-labeled neurons (rectangles in K, N). 
 
Suppl. Figure 12, related to Figure 6. Summary of the hierarchical organization of the face patch 
system. The hierarchical relationships between the face patches according to our quantitative 
layer analysis are shown. The patch on the left in bold in each diagram is the injected patch, while 
the patches on the right are connected to it. The direction of the arrow indicates the direction of 
the axons. The color indicates the hierarchy: blue = feedforward connection, red = feedback, 
green = ambiguous. In monkey B, we injected both left and right AL, but we only show the 
connections of the right AL because the injection in the left AL was mainly confined to superficial 
layers. 
 
Suppl. Figure 13, related to Figure 6. Summary of the connections of the face patches on an 
inflated view of the brain (lateral view, left column; ventral view, right column). The shaded colors 
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on the surface of the brain indicate the cytoarchitectonic areas: dark yellow: V2, dark green: V3, 
purple: V4, red: TEO, gray: TE, light green: TFO, light purple: TF, cyan: TH, ochre: perirhinal 
cortex. V2, V3 and V4 are further divided into a ventral and a dorsal portion (dashed white line). 
 
 
 












Figure S13
Table S1
left AM right PL right ML right  MF right  AL right  AF
tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot
inj. site x x 0 0 0 0 554 94.3 13
0 0 x x 218 37.3 98 67.5 inj. site 560
left AM right PL right ML right  MF right  AL right  AF
tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot
407 47.42 x x 0 0 0 0 0 0
395 64.81 x x 83 15.66 0 0 0 0 0
638 98.9 x x 3025 47.78 642 78.5 inj. site 0
0 0 x x 808 64.85 1018 32.5 1222 92.47 332
left AM right PL right ML right  MF right  AL right  AF
tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot
120 100 x x 44 100 0 0 0 0 0
78 100 x x 0 0 0 0 0 0 0
186 94.6 x x 0 0 0 0 0 0 0
inj. site x x 0 0 0 0 90 86.66 0
0 0 x x inj. site 0 0 195 76.41 0
0 0 x x 1168 95.42 0 0 inj. site 0 0
0 0 x x 0 0 0 0 0 0 0
right  AM IT outside of the face patches dl PFC (ipsi)
% sup.l. tot % sup.l. tot % sup.l.
100 110 98.1 334 9 100
50.5 324 88.1 112 0 100
right  AM IT outside of the face patches dl PFC (ipsi)
% sup.l. tot % sup.l. tot % sup.l.
0 0 0 836 0 0
0 0 0 135 1 100
0 1590 20.56 630 0 0
88.88 inj. site 361 0 0
right  AM accessory. patch (lh) IT outside of the face patches dl PFC (ipsi)
% sup.l. tot % sup.l. tot % sup.l. tot % sup.l.
0 x x 0 100 130 0 0
0 x x 103 125 0 0
0 x x 97 100 174 0 0
0 x x 0 373 0 0
0 x x 0 42 0 0
0 x x 0 156 0 0
0 x x 0 256 0 0
OFC (ipsi) TEO, posterior to PL (ipsi) l. V4 r. V4 l.V3 l. V2 perirh. c. (ipsi)
tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot
6 100 0 0 0 0 0 0 0 0 0 0 0
9 100 0 0 0 0 0 0 0 0 0 0 0
OFC (ipsi) TEO, posterior to PL (ipsi) l. V4 r. V4 l.V3 l. V2 perirh. c. (ipsi)
tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot
0 0 687 18% 4796 56% 0 0 1602 75% 318 93% 0
26 83 0 0 41 68% 0 0 0 0 0 0 0
12 100 0 0 0 0 0 0 0 0 0 0 56
10 100 0 0 0 0 0 0 0 0 0 0 144
OFC (ipsi) TEO, posterior to PL (ipsi) l. V4 r. V4 l.V3 l. V2 perirh. c. (ipsi)
tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot % sup.l. tot
0 0 0 0 0 0 0 0 0 0 372 100 0
0 0 0 0 138 100 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 334 100 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
TF (ipsi) TFO (ipsi) TH pulvinar (ipsi) amygdala (ipsi) claustrum (ipsi)
tot tot tot tot tot
0 0 0 0 0 114
0 0 0 0 0 0
TF (ipsi) TFO (ipsi) TH pulvinar (ipsi) amygdala (ipsi) claustrum (ipsi)
tot tot tot tot tot
0 0 0 11 0 35
0 0 0 0 0 33
268 78 0 93 40 23
133 109 0 74 120 11
TF (ipsi) TFO (ipsi) TH (ipsi) pulvinar (ipsi) amygdala (ipsi) claustrum (ipsi)
tot tot tot tot tot
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 76 0 0
0 72 37 190 0 726
0 0 0 0 0 0
